Patents-Review.com
ClassID:

20934 ⎘

A61K38/1761 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals Apoptosis related proteins, e.g. Apoptotic protease-activating factor-1 (APAF-1), Bax, Bax-inhibitory protein(s)(BI; bax-I), Myeloid cell leukemia associated protein (MCL-1), Inhibitor of apoptosis [IAP] or Bcl-2

Recent Application in this class:
#1
20260130910
2026-05-14

METHODS OF TREATING CANCERS

 #2
20250387461
2025-12-25

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

 #3
20250375388
2025-12-11

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

 #4
20250352614
2025-11-20

PEPTIDE THERAPEUTICS FOR THE TREATMENT OF CANCER AND USES THEREOF

 #5
20250306026
2025-10-02

COMPOSITIONS, ASSAYS, AND METHODS FOR DIRECT MODULATION OF FATTY ACID METABOLISM

 #6
20250270268
2025-08-28

AMELIORATION AND TREATMENT OF INFARCTION DAMAGE

 #7
20250268842
2025-08-28

Compositions for reducing oxidative stress

 #8
20250241985
2025-07-31

NANOLIPOSOME COMPOSITIONS AND METHODS OF TREATING STROKE

 #9
20250213651
2025-07-03

THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE

 #10
20250163115
2025-05-22

BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss

 #11
20250108090
2025-04-03

THERAPEUTIC AGENT FOR ISCHEMIC DISEASE

 #12
20250082723
2025-03-13

METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF TUMORS

 #13
20240398896
2024-12-05

INFLAMMASOME INHIBITION

 #14
20240317829
2024-09-26

APPLICATION OF APOPTOSIS INHIBITOR 5 (API5) FOR EPITHELIAL RESTITUTION

 #15
20240307199
2024-09-19

METHODS AND SYSTEMS FOR ANEURYSM STABILIZATION AND TREATMENT

 #16
20240285728
2024-08-29

TARGETED PROTEIN DELIVERY TO MAMMALIAN EMBRYOS AND THERAPEUTIC APPLICATIONS USING EXOSOMES

 #17
20240269231
2024-08-15

Methods for treating cancers using fat specific protein 27 (FSP27) compositions

 #18
20240228565
2024-07-11

AMELIORATION AND TREATMENT OF INFARCTION DAMAGE

 #19
20240197895
2024-06-20

COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH MITOCHONDRIAL COMPLEX I DEFICIENCY USING CASPASE-9 SIGNALING PATHWAY INHIBITORS

 #20
20240197824
2024-06-20

ANTI-SENESCENCE COMPOUNDS AND USES FOR THE TREATMENT OF CANCER

 #21
20240174729
2024-05-30

HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE

 #22
20240156905
2024-05-16

FAS-ASSOCIATED FACTOR 1 (FAF1)-LOADED EXOSOMES AND USE THEREOF AS ANTI-CANCER AGENT

 #23
20240115677
2024-04-11

Cancer Stem Cell Targeted Cancer Vaccines

 #24
20240092849
2024-03-21

SELECTIVE MCL-1 BINDING PEPTIDES

 #25
20240067689
2024-02-29

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

 #26
20240066098
2024-02-29

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

 #27
20240058417
2024-02-22

AMELIORATION AND TREATMENT OF INFARCTION DAMAGE

 #28
20240050527
2024-02-15

METHODS OF TREATING AGE-RELATED MACULAR DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF

 #29
20230263888
2023-08-24

MONOCYTES INDUCING ANTIGEN-SPECIFIC TOLERANCE, ENGINEERED MONOCYTES, AND METHOD OF USE THEREOF

 #30
20230235000
2023-07-27

TREATMENT OF NEURODEGENERATIVE PROTEINOPATHIES USING FAS APOPTOSIS INHIBITORY MOLECULE (FAIM) OR A FRAGMENT AND/OR A MIMETIC THEREOF

 #31
20230233647
2023-07-27

USE OF AN INHIBITOR OF ACTIN REMODELING MODULATOR FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF SLEEP DEPRIVATION-INDUCED MEMORY DEFICIT

 #32
20230228759
2023-07-20

COMPOSITIONS, ASSAYS, AND METHODS FOR DIRECT MODULATION OF FATTY ACID METABOLISM

 #33
20230181466
2023-06-15

BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES

 #34
20230093238
2023-03-23

Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)

 #35
20230090099
2023-03-23

IMPROVED ANTI-SENESCENCE COMPOUNDS AND USES THEREOF

 #36
20230077821
2023-03-16

BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss

 #37
20230059413
2023-02-23

Methods for treating cancers using fat specific protein 27 (FSP27) compositions

 #38
20220401491
2022-12-22

MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD, AND USE THEREOF

 #39
20220372096
2022-11-24

Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof

 #40
20220370555
2022-11-24

Selective cell death-inducing enzyme system

 #41
20220348620
2022-11-03

Engineered Peptide and Peptide Mimetic Compositions and Methods

 #42
20220323543
2022-10-13

FOCAL TREATMENT OF PROSTATE CANCER

 #43
20220313460
2022-10-06

Methods and systems for aneurysm stabilization and treatment

 #44
20220273778
2022-09-01

METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE

 #45
20220265767
2022-08-25

HIGH CONCENTRATION CELL PENETRATING CASPASE INHIBITOR CONJUGATES, COMPOSITIONS AND METHODS THEREOF

 #46
20220175877
2022-06-09

METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE

 #47
20220175688
2022-06-09

POLYMERIC NANOPARTICLES

 #48
20220098260
2022-03-31

BH4 Stabilized Peptides And Uses Thereof

 #49
20220088133
2022-03-24

Nanoliposome Compositions And Methods Of Treating Stroke

 #50
20220048965
2022-02-17

INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF

 #51
20220000975
2022-01-06

Therapeutic agent for neurodegenerative disease

 #52
20210363207
2021-11-25

SELECTIVE MCL-1 BINDING PEPTIDES

 #53
20210361742
2021-11-25

PEPTIDE THERAPEUTICS FOR THE TREATMENT OF CANCER AND USES THEREOF

 #54
20210246183
2021-08-12

Interleukin-2 fusion proteins and uses thereof

 #55
20210187069
2021-06-24

DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS

 #56
20210186964
2021-06-24

Methods of treating cancers

 #57
20210177907
2021-06-17

ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT

 #58
20210169980
2021-06-10

Autophagy inhibitors

 #59
20210106538
2021-04-15

Compositions and methods for delivery of biomacromolecule agents

 #60
20210095005
2021-04-01

Peptide for treating cancer

 #61
20210093701
2021-04-01

Cancer stem cell targeted cancer vaccines

 #62
20210040176
2021-02-11

High affinity PD-1 agents and methods of use

 #63
20210030842
2021-02-04

Focal treatment of prostate cancer

 #64
20200408767
2020-12-31

Compositions, assays, and methods for direct modulation of fatty acid metabolism

 #65
20200390855
2020-12-17

COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS FOR TREATING CANCER

 #66
20200352899
2020-11-12

Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss

 #67
20200299348
2020-09-24

Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof

 #68
20200297813
2020-09-24

Peptides and method for treatment of cardiac arrest

 #69
20200297812
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #70
20200297811
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #71
20200297810
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #72
20200297809
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #73
20200297808
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #74
20200297807
2020-09-24

Compositions and methods for treating cancer

 #75
20200297806
2020-09-24

Compositions and methods for treating cancer

 #76
20200297805
2020-09-24

Compositions and methods for treating cancer

 #77
20200297804
2020-09-24

Compositions and methods for treating cancer

 #78
20200297803
2020-09-24

Compositions and methods for treating cancer

 #79
20200297802
2020-09-24

Compositions and methods for treating cancer

 #80
20200276267
2020-09-03

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #81
20200268846
2020-08-27

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #82
20200268845
2020-08-27

Compositions and methods for treating cancer

 #83
20200268844
2020-08-27

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #84
20200268843
2020-08-27

Compositions and methods for treating cancer

 #85
20200268842
2020-08-27

Compositions and methods for treating cancer

 #86
20200268841
2020-08-27

Compositions and methods for treating cancer

 #87
20200268840
2020-08-27

Compositions and methods for treating cancer

 #88
20200246429
2020-08-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

 #89
20200230207
2020-07-23

TREATMENT OF BONE GROWTH DISORDERS

 #90
20200222502
2020-07-16

Methods for treating cancers using fat specific protein 27 (FSP27) compositions

 #91
20200215118
2020-07-09

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ATOPY CONTAINING EXOSOMES DERIVED FROM NEURAL STEM CELLS

 #92
20200046816
2020-02-13

Compositions and Methods for Antigen-Specific Tolerance

 #93
20190390203
2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

 #94
20190380957
2019-12-19

Protein Hydrogels For Treatment Of Neovascular Disease

 #95
20190364859
2019-12-05

Preventive or therapeutic agent for kidney disease

 #96
20190359669
2019-11-28

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

 #97
20190338000
2019-11-07

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

 #98
20190336577
2019-11-07

Methods and compositions relating to the treatment of tumors

 #99
20190309038
2019-10-10

Engineered potent cytotoxic stapled BH3 peptides

 #100
20190298799
2019-10-03

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

 #101
20190247464
2019-08-15

Compositions and methods for inducing thrombopoiesis

 #102
20190203231
2019-07-04

Methods for treating cells containing fusion genes

 #103
20190201381
2019-07-04

Compositions for cryopreservation and methods of use thereof

 #104
20190183965
2019-06-20

Methods and compositions comprising a C-terminal Bax peptide

 #105
20190175752
2019-06-13

Membrane-lytic block copolymers

 #106
20190161525
2019-05-30

Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain

 #107
20190160147
2019-05-30

Treatment of heart failure with preserved ejection fraction

 #108
20190142870
2019-05-16

Enhanced reconstitution and autoreconstitution of the hematopoietic compartment

 #109
20190133963
2019-05-09

POLYMERIC NANOPARTICLES

 #110
20190119357
2019-04-25

MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF

 #111
20190100568
2019-04-04

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #112
20190100567
2019-04-04

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #113
20190092822
2019-03-28

BH4 stabilized peptides and uses thereof

 #114
20190091291
2019-03-28

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

 #115
20190077840
2019-03-14

SELECTIVE MCL-1 BINDING PEPTIDES

 #116
20190071469
2019-03-07

THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES

 #117
20190060236
2019-02-28

Drug delivery means

 #118
20190046610
2019-02-14

Use of AAC-11 inhibitors for the treatment of viral infection

 #119
20190038676
2019-02-07

MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD, AND USE THEREOF

 #120
20190030126
2019-01-31

Inhibitors of the Interaction BCL-2 L10 / IP3 Receptors

 #121
20190016767
2019-01-17

Multimodal trail molecules expressed in T cells

 #122
20190002514
2019-01-03

Peptides binding to Bfl-1

 #123
20180362623
2018-12-20

Methods and compositions for promoting thermogenic potential

 #124
20180296690
2018-10-18

PROTEIN CONJUGATES

 #125
20180296640
2018-10-18

Peptides and method for treatment of cardiac arrest

 #126
20180289771
2018-10-11

Methods for treating cancer using PS-targeting antibodies with immuno-oncology agents

 #127
20180237485
2018-08-23

Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof

 #128
20180228763
2018-08-16

Method of treating leukemia utilizing somatic cell reprogramming

 #129
20180179545
2018-06-28

Reduction of lipase activity in product formulations

 #130
20180140670
2018-05-24

Compositions, articles of manufacture and methods for treating cancer

 #131
20180140660
2018-05-24

Compositions and methods for treating cancer

 #132
20180117089
2018-05-03

Enhanced reconstitution and autoreconstitution of the hematopoietic compartment

 #133
20180051060
2018-02-22

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

 #134
20180042994
2018-02-15

METHODS OF TREATING DISEASES RELATED TO MITOCHONDRIAL FUNCTION

 #135
20180030109
2018-02-01

Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor

 #136
20170258765
2017-09-14

Priming of pancreatic tumor cells and cancer stem cells to TRAIL-induced apoptosis

 #137
20170240924
2017-08-24

Methods for treating cells containing fusion genes

 #138
20170239332
2017-08-24

Regeneration of Inner Ear Cells

 #139
20170233451
2017-08-17

High affinity PD-1 agents and methods of use

 #140
20170226170
2017-08-10

Calbindin and BH3 domain chimeric proteins and methods for use

 #141
20170226168
2017-08-10

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

 #142
20170216399
2017-08-03

COMPOSITIONS, METHODS AND USES FOR PROTECTING WHITE BLOOD CELLS FROM SUPPRESSION OR DEATH

 #143
20170190754
2017-07-06

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

 #144
20170173182
2017-06-22

Composition for mRNA delivery

 #145
20170172120
2017-06-22

Preventive or therapeutic agent for kidney disease

 #146
20170101400
2017-04-13

Trail enhancers for the selective killing of cancer cells

 #147
20170020959
2017-01-26

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

 #148
20160376336
2016-12-29

Engineered potent cytotoxic stapled BH3 peptides

 #149
20160333064
2016-11-17

Biodegradable matrix comprising stem cells that express soluble TRAIL

 #150
20160312226
2016-10-27

Reduction of lipase activity in product formulations

 #151
20160271212
2016-09-22

Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use

 #152
20160243194
2016-08-25

Puma protein expression vector and use thereof in gene therapy

 #153
20160237135
2016-08-18

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #154
20160229901
2016-08-11

Interleukin-2 fusion proteins and uses thereof

 #155
20160215035
2016-07-28

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #156
20160213747
2016-07-28

Clusterin pharmaceuticals and treatment methods using the same

 #157
20160206694
2016-07-21

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

 #158
20160158381
2016-06-09

NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES

 #159
20160151455
2016-06-02

Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use

 #160
20160143995
2016-05-26

Method of treating intracellular infection

 #161
20160115211
2016-04-28

Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)

 #162
20160108100
2016-04-21

Interference peptides and use thereof

 #163
20160031959
2016-02-04

BH4 stabilized peptides and uses thereof

 #164
20150359841
2015-12-17

Methods and compositions comprising a C-terminal Bax peptide

 #165
20150352047
2015-12-10

Drug delivery means

 #166
20150266968
2015-09-24

Polypeptides capable of cellular internalization

 #167
20150238569
2015-08-27

Use of miR-494 to modulate TRAIL-induced apoptosis through BIM down-regulation

 #168
20150164950
2015-06-18

Enhanced reconstitution and autoreconstitution of the hematopoietic compartment

 #169
20150139939
2015-05-21

Cancer stem cell targeted cancer vaccines

 #170
20150125430
2015-05-07

Compositions and methods for inducing thrombopoiesis

 #171
20150094268
2015-04-02

Prophylactic or therapeutic agent for hepatic diseases

 #172
20150045310
2015-02-12

Engineered potent cytotoxic stapled BH3 peptides

 #173
20150038433
2015-02-05

Clusterin pharmaceuticals and treatment methods using the same

 #174
20140342994
2014-11-20

Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof

 #175
20140341846
2014-11-20

METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS

 #176
20140336134
2014-11-13

IAP BIR domain binding compounds

 #177
20140255299
2014-09-11

Methods and compositions comprising a C-terminal Bax peptide

 #178
20140093499
2014-04-03

PHARMACEUTICAL COMBINATIONS COMPRISING DUAL ANGIOPOIETIN-2 / DLL4 BINDERS AND ANTI-VEGF AGENTS

 #179
20140093498
2014-04-03

PHARMACEUTICAL COMBINATIONS COMPRISING DUAL ANGIOPOIETIN-2 / DLL4 BINDERS AND ANTI-VEGF-R AGENTS

 #180
20140086907
2014-03-27

Treatment and bioluminescent visualization using multimodal TRAIL molecules

 #181
20140037748
2014-02-06

REDOX RESPONSIVE POLYMERIC NANOCAPSULES FOR PROTEIN DELIVERY

 #182
20130345116
2013-12-26

Composition Containing Trail for Prevention or Treatment of Metabolic Diseases

 #183
20130281381
2013-10-24

Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans

 #184
20130071411
2013-03-21

IAP BIR domain binding compounds

 #185
20120316119
2012-12-13

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

 #186
20120309050
2012-12-06

System for increasing gene expression and vector comprising the system

 #187
20120289452
2012-11-15

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NECROSIS

 #188
20120149648
2012-06-14

Therapeutic peptidomimetic macrocycles

 #189
20120144504
2012-06-07

CASPASE-8 AND SKIN DISEASE

 #190
20110263510
2011-10-27

Methods of Inhibiting Cell Death or Inflammation in a Mammal

 #191
20110224133
2011-09-15

Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases

 #192
20110171202
2011-07-14

METHOD OF TREATING HEARING LOSS USING XIAP

 #193
20110130325
2011-06-02

Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same

 #194
20110105412
2011-05-05

Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS

 #195
20110071089
2011-03-24

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

 #196
20110065643
2011-03-17

Clusterin Pharmaceuticals and Treatment Methods Using the Same

 #197
20110021440
2011-01-27

APOPTOTIC PATHWAY TARGETING FOR THE DIAGNOSIS AND TREATMENT OF CANCER

 #198
20110009342
2011-01-13

USES OF PDCD5 POLYPEPTIDE FOR TUMOR CHEMOTHERAPY AND ORGAN PROTECTION

 #199
20100317598
2010-12-16

Isolated BRCA1 peptides and method of use

 #200
20100298215
2010-11-25

Synthetic apolipoprotein E mimicking polypeptides and methods of use

 #201
20100297094
2010-11-25

THERAPY OR PREVENTION OF DISEASES WITH CELLS OR CELL SUPERNATANT

 #202
20100292200
2010-11-18

Methods for Modulating Apoptosis in Platelets

 #203
20100273704
2010-10-28

Methods of modulating cellular homeostatic pathways and cellular survival

 #204
20100226878
2010-09-09

Methods of inhibiting photoreceptor apoptosis

 #205
20100221261
2010-09-02

IAP BIR DOMAIN BINDING COMPOUNDS

 #206
20100189802
2010-07-29

Method for treatment of vascular hyperpermeability

 #207
20100113338
2010-05-06

PROPHYLACTIC OR THERAPEUTIC AGENT FOR CORNEAL/CONJUNCTIVAL DISEASE

 #208
20100075897
2010-03-25

METHOD FOR SUSTAINEDLY RELEASING BIOACTIVE PEPTIDES AND APPLICATION THEREOF

 #209
20100016218
2010-01-21

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

 #210
20090275519
2009-11-05

Therapeutic peptidomimetic macrocycles

 #211
20090069223
2009-03-12

Method for treatment of vascular hyperpermeability

 #212
20090053186
2009-02-26

Therapy for primary and metastatic cancers

 #213
20090018078
2009-01-15

Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same

 #214
20080207525
2008-08-28

IAP BIR domain binding compounds

 #215
20080206287
2008-08-28

Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands

 #216
20080131400
2008-06-05

Vector system

 #217
20080069812
2008-03-20

IAP BIR domain binding compounds

 #218
20080044465
2008-02-21

THERAPY FOR CELLULAR ACCUMULATION IN CHRONIC INFLAMMATORY DISEASES

 #219
20070225264
2007-09-27

Drug delivery means

 #220
20070184021
2007-08-09

Use of caspase inhibitors as a therapeutic agent against radiation-induced injury

 #221
20070166288
2007-07-19

Formulation to improve survival of transplanted cells

 #222
20070081978
2007-04-12

Adeno-associated virus-mediated survivin mutants and methods related thereto

 #223
20060292122
2006-12-28

Adenoviral vectors for treating diseases

 #224
20060258581
2006-11-16

Methods and composition for derepressions of IAP-inhibited caspase

 #225
20060257371
2006-11-16

Adenoviral vectors for treating diseases

 #226
20060257370
2006-11-16

Adenoviral vectors for treating diseases

 #227
20050288368
2005-12-29

Compositions and methods for treating and preventing necrosis

 #228
20050095270
2005-05-05

Drug delivery to the inner ear and methods of using same